The Biotech Investor: How to Profit from the Coming Boom in Biotechnology
Premium Members save an extra 10% and all Members collect stamps to save with Rewards. 10 stamps = $5. Learn More
"Tom Abate's reporting on biotechnology has always been ahead of the times. The Biotech Investor tackles the brave new world of stem cells, genomics, and clones and comes up a winner." —Thom Calandra, editor in chief, CBS MarketWatch
In The Biotech Investor, San Francisco Chronicle biotechnology reporter Tom Abate explains the science, finances, time horizon, and technological and commercial potential of this burgeoning industry.
Abate provides guidelines for assessing company leadership, ea...
























